Clinicopathological Significance of S100A4 Expression in Non-small Cell Lung Carcinomas
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : S100A4 has been implicated in invasion and metastasis of various malignant tumors. The aim of this study was to investigate whether or not S100A4 plays an important role in non-small cell lung carcinomas (NSCLCs). Methods : Sixty-seven patients with NSCLC including 37 with squamous cell carcinomas (SCCs) and 30 with adenocarcinomas (ADs) who had undergone surgical resection were analyzed. S100A4 expression was analyzed by immunohistochemistry using tissue microarray blocks. Results : S100A4 expression was positive in 56 (83.6%) of 67 NSCLC cases. ADs were more frequently S100A4 positive than SCCs (p = 0.017). However, no significant correlation was observed between S100A4 expression and age, gender, pT, pN or tumor, node and metastasis (TNM) stage. Two distant metastatic cases revealed an S100A4 positive reaction. Kaplan-Meier survival curves with the logrank test showed no correlation with 3-year survival (p = 0.782) or 5-year survival (p = 0.227) in either group of patients according to S100A4 expression. Conclusions : S100A4 expression was not correlated with age, gender, pT, pN or TNM stage or survival in patients with NSCLCs. Therefore, S100A4 expression may not be useful as a prognostic marker for NSCLCs. However, S100A4 expression showed a higher positivity in ADs than in SCCs.
Abstract
Background : S100A4 has been implicated in invasion and metastasis of various malignant tumors. The aim of this study was to investigate whether or not S100A4 plays an important role in non-small cell lung carcinomas (NSCLCs). Methods : Sixty-seven patients with NSCLC including 37 with squamous cell carcinomas (SCCs) and 30 with adenocarcinomas (ADs) who had undergone surgical resection were analyzed. S100A4 expression was analyzed by immunohistochemistry using tissue microarray blocks. Results : S100A4 expression was positive in 56 (83.6%) of 67 NSCLC cases. ADs were more frequently S100A4 positive than SCCs (p = 0.017). However, no significant correlation was observed between S100A4 expression and age, gender, pT, pN or tumor, node and metastasis (TNM) stage. Two distant metastatic cases revealed an S100A4 positive reaction. Kaplan-Meier survival curves with the logrank test showed no correlation with 3-year survival (p = 0.782) or 5-year survival (p = 0.227) in either group of patients according to S100A4 expression. Conclusions : S100A4 expression was not correlated with age, gender, pT, pN or TNM stage or survival in patients with NSCLCs. Therefore, S100A4 expression may not be useful as a prognostic marker for NSCLCs. However, S100A4 expression showed a higher positivity in ADs than in SCCs.
참고문헌 (30)
- Kumar V, "Robbins and Cotran: pathologic basis of disease. 8th ed", pp.721~731 (2010), Saunders-Elsevier
- [URL]
- Toloza EM, "Targeted therapy for non-small cell lung cancer", Semin Thorac Cardiovasc Surg, 17, pp.199~204 (2005)
- Sherbet GV, "Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy", Cancer Lett, 280, pp.15~30 (2009)
- Cajone F, "Stathmin is involved in S100A4-mediated regulation of cell cycle progression", Clin Exp Metastasis, 17, pp.865~871 (1999)
- Jackson-Grusby LL, "A growth-related mRNA in cultured mouse cells encodes a placental calcium binding protein", Nucleic Acids Res, 15, pp.6677~6690 (1987)
- Schmidt-Hansen B, "Functional significance of metastasis-inducing S100A4(Mts1)in tumorstroma interplay", J Biol Chem, 279, pp.24498~24504 (2004)
- Shi Y, "Ribonucleic acid interference targeting S100A4(Mts1)suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model", J Clin Endocrinol Metab, 91, pp.2373~2379 (2006)
- Matsumoto K, "Expression of S100A2 and S100-A4 predicts for disease progression and patient survival in bladder cancer", Urology, 70, pp.602~607 (2007)
- Yao R, "The S100 proteins for screening and prognostic grading of bladder cancer", Histol Histopathol, 22, pp.1025~1032 (2007)
- Rudland PS, "Prognostic significance of the metastasis-inducing protein S100A4(p9Ka)in human breast cancer", Cancer Res, 60, pp.1595~1603 (2000)
- Lee WY, "Expression of S100A4 and Met:potential predictors for metastasis and survival in early-stage breast cancer", Oncology, 66, pp.429~438 (2004)
- Zou M, "Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis:identification of S100A4(Mts-1)gene overexpression as a poor prognostic marker for thyroid carcinoma", J Clin Endocrinol Metab, 89, pp.6146~6154 (2004)
- Yoon CS, "Expression of S100A4,E-cadherin,alpha-and beta-catenin in gastric adenocarcinoma", Hepatogastroenterology, 55, pp.1916~1920 (2008)
- Ai KX, "Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer", World J Gastroenterol, 14, pp.1931~1935 (2008)
- Kimura K, "Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer", Int J Oncol, 16, pp.1125~1131 (2000)
- Matsubara D, "Differential expression of S100A2 and S100A4 in lung adenocarcinomas:clinicopathological significance,relationship to p53 and identification of their target genes", Cancer Sci, 96, pp.844~857 (2005)
- Tsuna M, "Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma", Anticancer Res, 29, pp.2547~2554 (2009)
- Miyazaki N, "Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression", Int J Oncol, 28, pp.1369~1374 (2006)
- Travis WD, "Reporting lung cancer pathology specimens:impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee", Histopathology, 54, pp.3~11 (2009)
- Moore BW, "A soluble protein characteristic of the nervous system", Biochem Biophys Res Commun, 19, pp.739~744 (1965)
- Tarabykina S, "Metastasis-associated protein S100A4:spotlight on its role in cell migration", Curr Cancer Drug Targets, 7, pp.217~228 (2007)
- Bolander A, "Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma", Melanoma Res, 18, pp.412~419 (2008)
- Kriajevska M, "Metastasis-associated protein Mts1(S100A4)inhibits CK2-mediated phosphorylation and self-assembly of the heavy chain of nonmuscle myosin", Biochim Biophys Acta, 1498, pp.252~263 (2000)
- Schäfer BW, "The S100 family of EF-hand calciumbinding proteins:functions and pathology", Trends Biochem Sci, 21, pp.134~140 (1996)
- Heizmann CW, "S100 proteins: structure, functions and pathology", Front Biosci, 7, pp.d1356~d1368 (2002)
- Emberley ED, "S100 proteins and their influence on pro-survival pathways in cancer", Biochem Cell Biol, 82, pp.508~515 (2004)
- Grigorian M, "Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1", S100A4 protein:functional consequences of their interaction, 2001, pp.276, 22699~22708
- Parker C, "Metastasis-associated mts1 gene expression correlates with increased p53 detection in the B16 murine melanoma", DNA Cell Biol, 13, pp.343~351 (1994)
- Cho YG, "Overexpression of S100A4 is closely associated with progression of colorectal cancer", World J Gastroenterol, 11, pp.4852~4856 (2005)